KATHRYN THOMPSON: Open Payments
NPI 1003182130 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 54 payments from 10 companies in 2025. Trend: 2023 $1,299 · 2024 $795 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $475 |
| Arcutis Biotherapeutics, Inc. | 25 | $219 |
| LEO Pharma Inc. | 1 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| PFIZER INC. | 1 | $30 |
| ARRAY BIOPHARMA INC | 1 | $27 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
Products named: SKYRIZI, Zoryve, ELAHERE, ANZUPGO, RINVOQ, LYNPARZA, DUPIXENT, TIVDAK.
Industry payments across TX — which companies pay providers there.
